Eli Lilly and Company

NYSE:LLY

As GLP-1 Brands Go Prime Time, Regulators Flag Growing Illicit Market

5 Small-cap Biotech ETFs to Watch

Silicon-Driven Health: AI Digital Twins and the US$1 Billion Pharma Deal

5 Biggest Pharmaceutical ETFs for Investors in 2026

Pharma Market Forecast: Top Trends for Pharma in 2026

Biotech Market Forecast: Top Trends for Biotech in 2026

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

The Conversation (0)

Latest News

More News

Latest News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES